Article

Tumour evolvability metrics predict recurrence beyond 10 years in locally-advanced prostate cancer

2022-06-16

Abstract excerpt

<title>Abstract</title> <p>Cancers evolve obeying Darwinian laws and therefore the evolutionary paradigm lays the ground for predictive oncology. However, the predictive power of evolutionary metrics in cancer has been seldom tested. There is a need for quantitative measurements in controlled clinical trials with long term follow-up information. This is particularly true in locally-advanced prostate cancer, which...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e76d830a-0905-5cb2-a639-bcbf0a8a8cba
DOI: 10.21203/rs.3.rs-1520593/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tumour evolvability metrics predict recurrence beyond 10 years in locally-advanced prostate cancerDOI 10.21203/rs.3.rs-1520593/v2Read

Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSemantic proximity Read

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapySemantic proximity Read

Analysis of evolutionary dynamics and clonal architecture in prostate cancerSemantic proximity Read

Clonal Evolution and Transcriptional Plasticity Shape Metastatic Dissemination Routes in Prostate CancerSemantic proximity Read

Tumor architecture and emergence of strong genetic alterations are bottlenecks for clonal evolution in primary prostate cancer.Semantic proximity Read

The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression.Semantic proximity Read

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole genome sequencing with histopathological featuresSemantic proximity Read

Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.Semantic proximity Read

Evolutionary Measures Show that Recurrence of DCIS is Distinct from Progression to Breast CancerSemantic proximity Read

MorphoITH: a framework for deconvolving intra-tumor heterogeneity using tissue morphology.Semantic proximity Read

Treatment-mediated selection of lethal prostate cancer clones defined by copy number architecturesSemantic proximity Read

Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial TherapySemantic proximity Read